RankAlpha logo
Back to Rankings

PLX

Protalix BiotherapeuticsA
NYSE American / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Above peers
vs peer average
PLX vs peer average
95/100
PLX vs. peer average (A vs. D)
Grade spread
C 2 · D 1 · F 5
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

ABOS is the first available peer comparator.

Similar-market-cap biotechnology comparator; direct product or indication overlap with PLX is not established.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerABOSAcumen
PLX
Protalix Biotherapeutics
ABOS
Acumen
Grade
A
F
Momentum
98
72
Value
66
41
Sentiment
87
28
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Defensive

Grade position vs ABOS

PLX / ABOS
Grade Position
Above peers
PLX vs. peer average (A vs. D)
95/100
Momentum
98
PLX
Value
66
PLX
Sentiment
87
PLX

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs PLX
1
ABOS
ABOS
F
20/100
+4
2
CHRS
CHRS
F
20/100
+4
3
CUE
CUE
F
20/100
+4
4
DERM
DERM
C
60/100
+2
5
ORMP
Oramed Pharmaceuticals Inc Common
F
20/100
+4
ABOS is the first peer returned for this comparison set.